Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 5;25(10):euad301.
doi: 10.1093/europace/euad301.

Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter-defibrillator

Ian Crozier  1 , Haris Haqqani  2 , Emily Kotschet  3 , Christopher Wiggenhorn  4 , Jeff Lande  4 , Amy Thompson  4 , Alan Cheng  4 , Varun Bhatia  4 , David O'Donnell  5
Affiliations

Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter-defibrillator

Ian Crozier et al. Europace. .

Abstract

Anteroposterior (left) and lateral (right) fluoroscopic images of fully implanted EV ICD system in situ. Image modified from Crozier et al.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: This work was sponsored by Medtronic Inc. Dr Crozier is a consultant for and has received research support and fellowship support from Medtronic, and has received grants from Boston Scientific. Dr O’Donnell is a consultant for Medtronic and Abbott. Dr Haqqani is a consultant for Medtronic, Abbott, and Boston Scientific. Dr Kotschet is a consultant for Medtronic. Ms Thompson, Dr Wiggenhorn, Dr Lande, Dr Cheng, and Dr Bhatia are employees of Medtronic Inc.

Figures

Graphical Abstract
Graphical Abstract
Anteroposterior (left) and lateral (right) fluoroscopic images of fully implanted EV ICD system in situ. Image modified from Crozier et al.
See this image and copyright information in PMC

References

    1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau Ret al. . Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225–37. - PubMed
    1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DSet al. . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877–83. - PubMed
    1. Lee KL, Hafley G, Fisher JD, Gold MR, Prystowsky EN, Talajic Met al. . Effect of implantable defibrillators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial. Circulation 2002;106:233–8. - PubMed
    1. Maisel WH, Moynahan M, Zuckerman BD, Gross TP, Tovar OH, Tillman DBet al. . Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA 2006;295:1901–6. - PubMed
    1. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider Set al. . Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007;115:2474–80. - PubMed

Grants and funding